Table 1.
Expression of PRP3 and the clinicopathological characteristics in cSCCs patients.
Item | n | PRP3 (+) | PRP3 (−) | P |
---|---|---|---|---|
cSCC tissues | 58 | 45 | 13 | <0.01 |
AK | 42 | 10 | 32 | |
Age (years) | ||||
≤60 | 28 | 22 | 6 | 0.916* |
>60 | 30 | 23 | 7 | |
Distant metastasis | ||||
+ | 24 | 16 | 8 | <0.05 |
− | 34 | 29 | 5 | |
TNM stage (AJCC) | ||||
I~II | 26 | 16 | 10 | <0.01 |
III~IV | 32 | 29 | 3 |
*No statistical significance was found with the Chi-square test/Chi-Square Goodness-of-Fit Test. TNM, tumor node and metastasis; AJCC, American Joint Committee on Cancer.